Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST)-early results of RTOG 0132

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570009749371022464
  • NII Article ID
    20001658692
  • Data Source
    • CiNii Articles

Report a problem

Back to top